Literature DB >> 9756781

Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food.

S M Abdel-Rahman1, G L Kearns.   

Abstract

Pleconaril is an orally active broad-spectrum antipicornaviral agent which demonstrates excellent penetration into the central nervous system, liver, and nasal epithelium. We report the results of a randomized two-way crossover study designed to characterize the disposition of a single dose (200 mg) of pleconaril oral solution in fed and fasting humans. Twelve healthy adult subjects (18.7 to 39 years of age) participated in this study. Each subject received a single 200-mg dose of pleconaril oral solution, both coadministered with a standard English breakfast and following a 10-h predose fast. There was a minimum 7-day washout period between pleconaril doses. Repeated blood samples (n = 10) were obtained over 24 h postdose, and the pleconaril level in plasma was quantified by gas chromatography. Plasma concentration-versus-time data were curve fitted for each subject by using a nonlinear weighted least-squares algorithm, and pharmacokinetic parameters were determined from the polyexponential estimates. Pleconaril disposition was best characterized by a one-compartment open model with first-order absorption. The apparent bioavailability of pleconaril oral solution was significantly increased with the administration of food. The area under the concentration-time curve and maximum concentration of pleconaril in plasma achieved following the standard English breakfast (i.e., 9.08 +/- 3.23 mg/liter . h and 1.14 +/- 0.58 mg/liter, respectively) were 2.2- and 2.5-fold higher, respectively than those achieved in the fasting state (i.e., 4.08 +/- 2.74 mg/liter . h and 0.46 +/- 0.30 mg/liter, respectively). Mean plasma pleconaril concentrations 12 h after a single 200-mg oral dose (fed, 0.25 +/- 0.2 mg/liter; fasting, 0.11 +/- 0.10 mg/liter) in healthy adults remained greater than that required to inhibit more than 90% of the enteroviruses in cell culture (i.e., 0.07 mg/liter). To enhance the oral bioavailability of pleconaril, coadministration with a fat-containing meal is recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756781      PMCID: PMC105923     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment.

Authors:  M A McKinlay; D C Pevear; M G Rossmann
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

Review 2.  Nonpolio enteroviruses and the febrile young infant: epidemiologic, clinical and diagnostic aspects.

Authors:  R Dagan
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

3.  Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983.

Authors:  R A Strikas; L J Anderson; R A Parker
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

4.  PCR for the diagnosis of enteroviral meningitis.

Authors:  A Thorén; A Widell
Journal:  Scand J Infect Dis       Date:  1994

5.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

Review 6.  Other viral agents of perinatal importance. Varicella, parvovirus, respiratory syncytial virus, and enterovirus.

Authors:  H L Keyserling
Journal:  Clin Perinatol       Date:  1997-03       Impact factor: 3.430

7.  Aseptic meningitis in infants < 2 years of age: diagnosis and etiology.

Authors:  L E Berlin; M L Rorabaugh; F Heldrich; K Roberts; T Doran; J F Modlin
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

8.  Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin.

Authors:  M J Abzug; H L Keyserling; M L Lee; M J Levin; H A Rotbart
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

Review 9.  Enteroviral infections of the central nervous system.

Authors:  H A Rotbart
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

  9 in total
  9 in total

1.  Predicting effect of food on extent of drug absorption based on physicochemical properties.

Authors:  Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

2.  Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network.

Authors:  G L Kearns; S M Abdel-Rahman; L P James; D L Blowey; J D Marshall; T G Wells; R F Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 3.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 4.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

5.  Diagnosis and Management of Enteroviral Infections of the Central Nervous System.

Authors:  José R. Romero
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.663

6.  A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions.

Authors:  Mohammed H Cherkaoui-Rbati; Stuart W Paine; Peter Littlewood; Cyril Rauch
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 7.  Pleconaril, a novel antipicornaviral agent.

Authors:  Naomi R Florea; Dana Maglio; David P Nicolau
Journal:  Pharmacotherapy       Date:  2003-03       Impact factor: 4.705

8.  Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.

Authors:  Luca Murer; Anthony Petkidis; Thomas Vallet; Marco Vignuzzi; Urs F Greber
Journal:  J Virol       Date:  2021-10-27       Impact factor: 5.103

9.  Antiviral agents in the critically ill child.

Authors:  Flor M Munoz
Journal:  Semin Pediatr Infect Dis       Date:  2005-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.